Nelipak Corp. says it has acquired Merrill’s Packaging, which specializes in custom thermoformed packaging for medical devices, pharmaceuticals, and other life sciences products. Merrill’s has manufacturing operations at its Burlingame, California, headquarters and in Alajuela, Costa Rica. Both sites are ISO 13485 certified and have ISO Class 8 cleanrooms. “We are excited to welcome the…

Thermo Fisher Scientific announced that it expanded its bioprocessing capabilities across Asia. The Waltham, Massachusetts-based company says the expansion reinforces its commitment to supporting the region’s growing biopharmaceutical industry. It plans to introduce a new Bioprocess Design Center in Hyderabad, India, in addition to expansions in existing Bioprocess Design Centers in Incheon, Korea, and Singapore.…

AstraZeneca announced today that it plans to invest $2 billion to expand its pharmaceutical manufacturing footprint in Maryland. The company plans to expand its flagship biologics manufacturing facility and construct a new state-of-the-art facility in Gaithersburg. It plans for the facilities to aid in the development and clinical supply of innovative molecules for use in…

Novartis announced today that it opened a new 10,000-square-foot radioligand therapy (RLT) manufacturing facility in California. The state-of-the-art site in Carlsbad marks the latest milestone in the company’s previously announced $23 billion investment in U.S. infrastructure over the next five years. Novartis says the Carlsbad facility opening allows it to seamlessly meet future demand for…

Small form factor hygienic sensors, along with fit for purpose full-featured transmitters, provide increased value for the life sciences Industry. Coriolis flow meters have long played a vital role in pharmaceutical applications. Biotech processes often involve high value materials and highly sensitive operations, making consistent and accurate mass flow measurement essential for maintaining tight control…

Samsung Biologics announced today that it completed the spinoff of its Samsung Bioepis unit to focus on leading as a pure-play CDMO. Following approval from its board, Samsung Biologics separated its investment and subsidiary management business to establish Samsung Epis Holdings. It finalized its Decision on Nov. 1 with plans to proceed with registration for…

Eli Lilly (NYSE:LLY) announced today that it plans to build a new $3 billion manufacturing facility in Katwijk, the Netherlands. Located within the Leiden Bio Science Park, the new project aims to expand Lilly’s capacity to produce oral medicines. The company also hopes to strengthen its global supply chain with the new plant. Indianapolis-based Lilly…

The lessons learned in mastering autologous manufacturing—where precision, flexibility, and data integrity are pushed to their limits—are shaping how biopharma advances efficiency and control across every process. The innovations happening in the personalized medicine space are some of the most exciting life sciences advancements in the history of humankind. Many of the autologous, patient-specific therapies…

Trelleborg has announced the grand opening of its expanded manufacturing facility and BioPharma Center of Excellence in Northborough, Massachusetts. The new facility for the Plymouth, Massachusetts-based company drives its strategy for growth in the biopharmaceutical industry. “Our expanded BioPharma Center of Excellence supports our goal of being the partner of choice for all leading biopharmaceutical…

Eli Lilly (NYSE:LLY) announced today that it plans to invest more than $1.2 billion to expand and modernize a manufacturing site in Puerto Rico. The company plans to integrate advanced technologies and expand production capacity within the existing campus at its Lilly del Caribe plant in Carolina, Puerto Rico. It hopes to support its growing…